08.06.2012 • News

Laura L. Parks appointed President and Business Unit Director at DSM Pharmaceutical Products

Laura L. Parks, Ph.D., currently Senior Vice President of Marketing & Sales for the DSM Pharmaceutical Products business group of Royal DSM has been appointed President and Business Unit Director of DSM Pharmaceuticals as of June 1, 2012.

Laura will continue to report to Alexander R. Wessels, President and Chief Executive Officer of DSM Pharmaceutical Products, as a member of the Management Team.

 

Dr. Parks joined DSM in 2008. Prior to DSM, she was with World Financial Group, and Solae (a Division of DuPont), a public company of over 10,000 employees, as Vice President of Sales.

 

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.